As part of the partnership, OBS Medical will assist TMS to commercially develop three novel variability-derived clinical decision support software products and to gain necessary regulatory approvals. The first Clinical Decision Support System (CDSS) in this suite of predictive analytics will be Extubation Advisor (EA).
Read More...
Managing Director Simon Didcote explains, “To market Visensia in Japan has been a long-term ambition of OBS Medical. The need to identify and prioritize patients who are unstable or showing early signs of deterioration in the era of the COVID pandemic has never been greater.”
Partnering with Nihon Kohden on this endeavour has been very rewarding in terms of their expertise and knowledge in advanced digital technology driven by data, as well as their mutual understanding of the clinical need for Visensia”. Now that we have market approval, we can begin to evidence the health economic benefits the technology enables, helping to drive adoption across the region.
Read More...
QardioMD+VSI is a remote monitoring solution that combines the data from Qardio’s range of award winning and medically accurate wearables, with the Visensia® predictive algorithm. This combination allows Clinicians to remotely review a patients’ vital signs in real time and to prioritise those patients according to the Visensia risk stratification algorithm – Visensia Safety Index (VSI).
Read More...
Now that research from the hospital shows that continuous monitoring in itself already results in one third fewer transfers to intensive care, the way is clear to investigate whether even more can be gained with the ‘predictive’ computer scores. Doctors and nurses are required by the new protocol to examine the computer’s alarm signals.
Read More...